Hemodynamic Determinants of Urine Output During Spinal Anesthesia
Launched by INSTITUTUL DE URGENŢĂ PENTRU BOLI CARDIOVASCULARE PROF.DR. C.C. ILIESCU · Feb 5, 2025
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how urine output is affected during spinal anesthesia, which is a type of pain relief used during surgery. The researchers want to understand the connection between urine output and blood pressure, specifically looking at mean arterial pressure (MAP). They will also measure hemoglobin levels and urine output while using a solution called Ringer's to help manage fluids during anesthesia. The goal is to gather important information that could lead to better fluid management practices during surgeries.
To participate in this study, you need to be an adult aged 18 or older and able to give written consent. However, some people may not be eligible, especially if they have certain medical conditions that make spinal anesthesia unsafe, such as severe bleeding disorders or certain heart problems. If you join the trial, you can expect to have your blood pressure and urine output monitored during your procedure, which will help researchers learn more about how to improve patient care during anesthesia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Written informed consent provided by patients or their legally authorized representatives.
- • Adults aged 18 years and older.
- Exclusion Criteria:
- * Contraindications to Spinal Anesthesia:
- • Patient refusal
- • Presence of coagulopathy.
- • Current use of anticoagulant or antiplatelet medications.
- • Critical or severe aortic stenosis or other fixed cardiac output states.
- • High risk of infection at the spinal needle insertion site.
- • Elevated intracranial pressure.
- • Allergy
- • Sepsis
- * Procedures Not Amenable to Spinal Anesthesia:
- • Planned concurrent procedures that cannot be performed under spinal anesthesia.
About Institutul De Urgenţă Pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu
The Institutul de Urgenţă pentru Boli Cardiovasculare Prof. Dr. C.C. Iliescu is a leading clinical research institution dedicated to advancing the understanding and treatment of cardiovascular diseases. Renowned for its commitment to innovative research and high-quality patient care, the institute conducts rigorous clinical trials aimed at developing new therapeutic strategies and improving clinical outcomes for patients with heart conditions. With a team of experienced professionals and state-of-the-art facilities, the institute plays a pivotal role in the cardiovascular research landscape, fostering collaboration and knowledge dissemination within the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bucharest, , Romania
Patients applied
Trial Officials
Robert Hahn, Professor
Study Chair
Karolinska Institutet: Stockholm, SE (Department of Clinical Sciences, Danderyd Hospital) Employment
Serban-Ion Bubenek-Turconi, Professor
Study Director
CC Iliescu Cardiovascular Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported